Greene M.H. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi / M.H. Greene, W.H. Clark Jr., M.A. Tucker et al. // Ann Intern Med. 1985. №102. P. 458–465.
Chan A.K., Han S.J., Choy W. Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history. Clin Neuropathol. Sep/Oct 2017;36(5):213-221.
Pilarski R., Carlo M., Cebulla C., et al, editors. BAP1 Tumor Predisposition Syndrome In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 2021. 2016 Oct 13 [updated 2020 Sep 17.
Black J.O. Xeroderma Pigmentosum Head Neck Pathol. 2016 Jun;10(2):139-44. Epub 2016 Mar 14.
Yang Q., Sheng Yi., Mengting L. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations. BMC Med Genet. 2019 Jun 13;20(1):106.
Lee S. Duffy D.L. McClenahan P. Lee K.J. McEniery E. Burke B. et al. Heritability of naevus patterns in an adult twin cohort from the Brisbane Twin Registry: a cross- sectional study. Br J Dermatol. 2016; 174: 356-363.
Ferrone, C.R. Clinicopathological features of and risk factors for multiple primary melanomas / C.R. Ferrone, L. Ben Porat, K.S. Panageas et al. // JAMA. 2005. № 294. P. 1647–1654. 15. Ferrone, C.
Stam-Posthuma, J.J. Multiple primary melanomas / Stam-Posthuma J.J., van Duinen C., Scheffer E. et al. // J Am Acad Dermatol. 2001. №44. P. 22–27.
Kang, S. Multiple primary cutaneous melanomas / S. Kang, R.L. Barnhill, M.C. Mihm // Cancer. 1992. №70. P. 1911–1916.
Marghoob, A.A. Basal cell and squamous cell carcinomas are important riskfactors for cutaneous malignant melanoma. Screening implications / A.A. Marghoob, J. Slade, T.G. Salopek et al. // Cancer. 1995 №75. Suppl. 2. P. 707–71
Pielop, J.A. Mycosis fungoides associated with malignant melanoma and dysplastic nevus syndrome / J.A. Pielop, I. Brownell, M. Duvic // Int J Dermatol. 2003. №42 P.116–122.
Ransohoff, K. J. Familial skin cancer syndromes increased melanoma risk /K. J. Ransohoff, P. D. Jaju, J. Y. Tang et al. // Journal of the American Academy of Dermatology. 2016. Vol. 74 №3 P. 423–434.
Read, J. Melanoma genetics / J. Read, K. A. W. Wadt, N. K. Hayward // Journal of Medical Genetics. 2015. №53. P. 1–14.
Greene, M.H. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi / M.H. Greene, W.H. Clark Jr., M.A. Tucker et al. // Ann Intern Med. 1985. №102. P. 458–465/
Fusaro, R.M. The FAMMM syndrome: epidemiology and surveillance strategies / R.M. Fusaro, H.T. Lynch // Cancer Invest. 2000. № 18 P. 670–680/
Psaty, E.L. Defining the patient at high risk for melanoma / E.L. Psaty, A. Scope, A.C. Halpern et al. // Int J Dermatol. 2010 Apr. Vol.49. №4 362-76.
Cust, A.E.. Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma / A.E. Cust, B.K. Armstrong, C. Goumas et al. // Int J Cancer. 2011. №128. P. 2425-35.
Stern, R.S. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study / R.S. Stern, K.T. Nichols, L.H. Vakeva // N Engl J Med. 1997. №336. P. 1041–1045.
Sanlorenzo, M. The Risk of Melanoma in Pilots and Cabin Crew: UV Measurements in Flying Airplanes / M. Sanlorenzo, I. Vujic, C. Posch et al. // JAMA Dermatol. 2015 Apr 1. Vol. 151. №4). 450-2.
Gandini, S. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors / S. Gandini, F. Sera, M.S. Cattaruzza et al. // Eur J Cancer. 2005. № 41. P. 2040–2059/
Elwood, J.M. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study / J.M. Elwood, R.P. Gallagher,A.J. Worth et al. // J Natl Cancer Inst. 1987. №78. P. 37–44/
Argenziano, G. Twenty nevi on the arms: a simple rule to identify patients younger than 50 years of age at higher risk for melanoma / G. Argenziano, J. Giacomel, I.Zalaudek et al. // Eur J Cancer Prev. 2014 Sep. №23(5). Р. 458-63
7. NHI consensus Conference: diagnosis and treatment of early melanoma. JAMA. 1992;251:1314-09
Moscarella, E. Problematic Lesions in Children / E. Moscarella, V. Piccolo G. Argenziano // Dermatol Clin 31 (2013) 535–547/
Alikhan, A, Ibrahimi OA, Eisen DB. Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis./ A. Alikhan, O.A. Ibrahimi, D.B. Eisen //J Am Acad Dermatol. 2012. №67 P. 495.e1–17 [quiz: 512–4].
Bonifazi, E. Malignant melanoma in children aged 0-12. Review of 289 cases of the literature / E. Bonifazi, M. Bilancia, A. Berloco et al. // Eur J Pediatr Dermatol. 2001. №11. P. 157–75/
Krengel, S. Melanoma risk in congenital melanocytic naevi: a systematic review / S. Krengel, A. Hauschild, T. Schafer // Br J Dermatol. 2006. №155. P. 1–8.
Kadonaga, J.N., Neurocutaneous melanosis: definition and review of the literature / J.N. Kadonaga, I.J. Frieden // J Am Acad Dermatol. 1991. №24 P.747–55
Zalaudek, I. Problematic lesions in elderly / I. Zalaudek, A. Lallas, C. Longo et al. // Dermatol Clin. 2013. №31. P. 549–564
Piepkorn M, Meyer LJ, Goldgar D, et al. The dysplastic melanocytic nevus: prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989;20:407-15.
C.G. Watts, M. Dieng, R.L. Morton, G.J. Mann, S.W. Menzies, A.E. Cust Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: a systematic review. Br J Dermatol. 2015 Jan;172(1):33-47
Greenhaw BN, Covington KR, Kurley SJ, Yeniay Y, Cao NA, Plasseraud KM, Cook RW, Hsueh EC, Gastman BR, Wei ML. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients. J Am Acad Dermatol. 2020 Sep;83(3):745-753. doi: 10.1016/j.jaad.2020.03.053. Epub 2020 Mar 27.